Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Milestone reached in Evotec, Bayer endometriosis collaboration

Aug. 4, 2016

Amicus Therapeutics to submit NDA in Japan for migalastat next year

Aug. 4, 2016

Boehringer Ingelheim Pharma patents AMPK activators

Aug. 4, 2016

HTIT makes milestone payment to Oramed for oral insulin product

Aug. 3, 2016

Abeona Therapeutics gives update on phase I/II study of MPS IIIA treatment

Aug. 3, 2016

REGENXBIO's RGX-121 wins FDA rare pediatric disease designation

Aug. 3, 2016

Orexigen Therapeutics completes acquisition of U.S. rights to Contrave

Aug. 2, 2016

Janssen Pharmaceutica introduces cannabinoid CB1 inverse agonists

Aug. 2, 2016

Setmelanotide as potential novel treatment of proopiomelanocortin deficiency

Aug. 1, 2016

Diamyd Medical signs agreement regarding ongoing GABA/GAD trial

Aug. 1, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...